Millennium Laboratories Release: CLAAD Recognizes SMART/Script as Top 5 Technology to Reduce Rx Abuse
Published: Nov 28, 2012
WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) today honored Atlantic Pharmaceuticals' SMART/Script as one of its "Top 5 Technologies To Reduce Prescription Drug Abuse."
"We are honored to have our SMART/Script formulation system recognized by CLAAD and Millennium Laboratories," said Anthony Soscia, President of Atlantic Pharmaceuticals. "We believe that utilization of the SMART/Script platform will have a meaningful impact on prescription drug abuse."
The Top 5 Technologies competition aims to increase awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.
Michael Barnes, spokesman for CLAAD, stated, "We support Atlantic Pharmaceuticals and other companies working to make medications less susceptible to abuse."
San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.
"We are proud to recognize Atlantic Pharmaceuticals for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories.
About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. CLAAD's National Prescription Drug Abuse Prevention Strategy identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy. Visit claad.org, and follow @claad_coalition.
About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety.
About Atlantic Pharmaceuticals, Inc.
Atlantic Pharmaceuticals is a specialty pharmaceutical company developing technologies to increase the difficulty of tampering with orally administered immediate and sustained release pharmaceuticals. The company is using its proprietary SMART/Script (SMART/Simple, controllable, resistant, insoluble, physical trap) platform to formulate ATLP-02, a tamper resistant, immediate release, orally delivered oxycodone dosage form.